Tracers / [90Y]Y-DOTATATE

[90Y]Y-DOTATATE

Also written as DOTATATE; DOTA-TATE; dotatate
Radionuclide
Y-90 t½ 3843.6 min
Modality
Therapy
Production route
Stage
Syntheses indexed
4

What it is

Compound class
DOTA-conjugated somatostatin analog
Target / mechanism
Somatostatin receptor (SSTR) binding PMID 41356201
Clinical application
Peptide receptor radionuclide therapy for SSTR-expressing neuroendocrine neoplasms PMID 41356201
Theranostic pair
<a href="/tracers/ga68-dotatate/">ga68-dotatate</a>

Regulatory status

FDA
EMA (centralised)
Other approvals
Brand names

Clinical use

Typical injected activity
Uptake time

Reported in the literature. Not a dosing recommendation.

Published syntheses

ModuleCassettePurificationYield %RCP %Precursor / supplierSource
DOTATATE41356201
2026 Theranostics
more than 97%DOTATATE26443981
2016 Nucl Med Commun
novel, self-shielded modular radiosynthesis system for fully automated preparation of PET and therapeutic radiopharmaceuticals
32293704
2020 Endokrynol Pol
>95%DOTA-TATE30770227
2019 Nucl Med Biol
A two-step radiochemical separation procedure based on selective precipitation of 90Y under alkaline conditions from 90Sr/90Y equilibrium mixture was developed.

Need this precursor?We can point you to suppliers for [90Y]Y-DOTATATE, or handle the enquiry for you.

Get in touch

Notes

Added at stage 21 from therapy-discovered.xlsx (bulk PubMed search by isotope/therapy-type/known-agent, not individually researched yet) -- 8 articles found. Target/mechanism, clinical application, indications, approval and precursor fields still need per-agent research and are intentionally left empty. Diagnostic pair signal at discovery: YES - Cu-64, Ga-68. Compound class inferred from precursor name (not stated outright) -- PMID 41356201: 'The DOTA-conjugated somatostatin analogs DOTATOC and DOTATATE were labeled with 68Ga for SSTR PET imaging and either 177Lu or 90Y for IA-PRRT'.